Dabogratinib (GMP), CAS [[2800223-30-5]] Preis auf Anfrage
Biozol Catalog Number:
MCE-HY-159642G
Supplier Catalog Number:
HY-159642G
Alternative Catalog Number:
MCE-HY-159642G-1UNIT
Manufacturer:
MedchemExpress
Category:
Biochemikalien
Dabogratinib (GMP) is Dabogratinib (HY-159642) produced by using GMP guidelines. GMP small molecules work appropriately as an auxiliary reagent for cell therapy manufacture. Dabogratinib is an orally active, selective FGFR3 inhibitor with an IC50 of 11 nM. Dabogratinib exhibits antitumor activity against urothelial carcinoma and solid tumors. Dabogratinib downregulates the FGFR3 and ERK1/2 signaling pathways, and induces tumor growth inhibition and regression in FGFR3-altered xenograft models. Dabogratinib promotes chondrocyte proliferation and differentiation, drives endochondral bone formation and overall body growth, partially restores long bone proportions, and improves craniofacial and spinal morphology. Dabogratinib can be used for the research of metastatic urothelial carcinoma, achondroplasia and hypochondroplasia[1][2][3].
Molecular Weight:
559.47
CAS Number:
[2800223-30-5]
Formula:
C25H24Cl2N6O3S
Target:
FGFR
Application Notes:
MCE Product type: GMP Small Molecules
* VAT and and shipping costs not included. Errors and price changes excepted
